TWC 2024 | 7th Theranostics World Congress

Welcome to the Theranostics World Congress 2024 retrospective! We invite you to journey back and explore the key moments, insightful presentations, and remarkable advancements showcased during TWC 2024. Join us as we reflect on the latest breakthroughs in Theranostics and revisit the spirit of collaboration and innovation that defines our congress. Enjoy your exploration!

March 22 – 24, 2024

The congress language was English

W SANTIAGO
Isidora Goyenechea 3000, Las Condes
Santiago, Chile

Information

Congress chairs

Congress President

Prof. Dr. Horacio Amaral Pineda
Santiago, Chile

Congress President

Dr. Vasko Kramer
Santiago, Chile

Co-Congress President

Prof. Dr. Frank Rösch
Berlin, Germany

Co-Congress President

Prof. Dr. Richard P. Baum
Wiesbaden, Germany

Dear colleagues and friends,

On behalf of the scientific board and organizing committee, it is our pleasure to extend a warm welcome and invite you to join us for the 7^th Theranostic World Congress (TWC) that will be held from 22^nd to 24^th of March 2024 in the beautiful city of Santiago, Chile.

The TWC is an international conference that brings together leading experts in the field from around the world. Our goal is to provide a platform for researchers, students, clinicians, and industry professionals to share their knowledge, learn and discuss the latest advancements in this exciting field.

Maintain the same spirit and format, the 7^th TWC program will cover a wide range of topics with dedicated sessions on prostate cancer, neuroendocrine tumors, targeting tumor microenvironment, new radioisotopes and their production, novel radiochemistry and chelators, combination therapies, patient access, and many others. We also encourage you to send us topic-related abstracts about your research to be shared either as poster or oral presentation.

We are also excited to announce a one-day pre-conference event for professionals from South America with the aim of extending access to Theranostics and increasing awareness. This event will provide radiochemists, nuclear medicine physicians and other healthcare professionals with the opportunity to learn more about the practical aspects of this emerging field.

We are confident that you will have an unforgettable experience attending the TWC in Santiago.

We are looking forward to seeing you in Santiago and to productive discussions and collaborations that will help advance the field and ultimately benefit patients worldwide.

Yours sincerely,

Horacio Amaral, Vasko Kramer, Richard Baum, Frank Rösch

A

Alonso, Omar (Centro Uruguayo de Imágenes Moleculares , Uruguay)

Avila Rodriguez, Miguel (UNAM, Ciudad de Mexico, Mexico)

B

Barboza, Marycel (Nuclear Medicine, Hospital Albert Einstein, Sao Paolo, Brasil)

Bastianello, Maria (Universidad de Buenos Aires, CEMIC, Argentina)

Buchpiguel, Carlos (Department of Radiology, University of Sao Paolo; Hospital Sirio Libanes, Brasil)

C

Casale, Guillermo (Laboratorio Bacon, Buenos Aires, Argentina)

E

Echtebehere, Elba (Nuclear Medicine, University of Campinas, Brasil)

F

Faccio, Fernando (Departamento de Imágenes Sanatorio San Gerónimo, Argentina)

Fernandez, Rene (Positronmed, Chile)

G

Granador, Carlos (Hospital Universitario San Ignaci, Colombia)

H

Huapaya, Danfer (Clinica Anglo Americana, Lima, Peru)

L

Lopez, Rafael (Sociedade Brasileira de Medicina Nuclear, Brasil)

M

Matushita, Cristina (Pontificia Universidad Catolica de Rio Grande do Sul, Brasil)

O

Olarte Casas, Miguel Angel (UNAM, Ciudad de Mexico, Mexico)

P

Perfecto Oliva, Juan (CENTIS, Cuba)

R

Racioppi, Silvina (Head of Nuclear Medicine Theranostics, IO Alex Fleming, Argentina)

Rey, Ana (Área Radioquímica, Facultad de Química, Universidad de la República, Uruguay)

Rodriguez, Jose Luis (Clinica Las Condes, Chile)

S

Savio, Eduardo (Centro Uruguayo de Imágenes Moleculares , Uruguay)

Program

A comprehensive overview of the sessions, speakers, and topics that fueled discussions and drove innovation during our congress. Dive into the program to rediscover the wealth of knowledge shared by experts in the field of Theranostics.

Main Topics

Patient Access & Healthcare System Readiness
Prostate Cancer
NET & other Cancers
Medical Physics & Instrumentation
Novel Targets, Chemistry, Indications

Updates on Radioisotope Production
Tumor Microenvironment
Combination Therapies
Industry Symposia & Exposition

... and much more

Download TWC Program Draft

Download PreCongress Program Draft

Program Overview

PreCongress

8:30 – 8:45
Opening Remarks

8:45 – 10:00
ICPO Academy

10:30 – 11:30
LATAM Symposium on Radiochemistry

11:30 – 12:30
LATAM Symposium on Medical Physics & Instrumentation

15:00 – 16:00
LATAM Symposium on Nuclear Medicine

16:00 – 17:00
LATAM Symposium on Patient Access, Regulation & Coverage

19:30 – 0:00
SPEAKERS WELCOME

TWC Congress

8:30 – 10:00
Opening Ceremony & Opening Lecture

10:30 – 11:15
Patient Access Session – Panel Discussion of ICPO/Oncidium

11:15 – 12:00
Healthcare System Readiness for RLT – Panel Discussion

13:30 – 15:00
Neuroendocrine Tumors & others

15:30 – 17:00
Prostate Cancer

17:00 – 17:30
ProstTIC24 Recap

17:30 – 18:30
Poster Session

19:30 – 0:00
SOCIAL EVENING - VISTA SANTIAGO (including transport to event)

8:30 – 10:00
Medical Physics & Instrumentation

10:45 – 11:45
Industry Session I
3B Pharmaceuticals GmbH
FAP: Therapy, Imaging, and Beyond

12:15 – 12:45
Industry Session II
Novartis
How Partnerships can support innovation & evolution of RLT in the future

13:00 – 13:30
Industry Session III
ITM Isotope Technologies Munich SE
Emitting Excellence: Illuminating the evolving landscape of Radiopharmaceutical Therapy

13:30 – 15:00
Novel Targets & Chemistry Session

15:30 – 16:30
TME Diagnostics

16:30 – 18:00
TME Therapeutics

18:00 – 18:20
TME – Panel Discussion

8:15 – 9:15
Current State of Isotope Production

10:30 – 11:15
Industry Session IV
Siemens Healthineers

11:45 – 12:30
Industry Session V
Joint Symposium
211At industrials within the World Astatine Community (WAC)

12:45 – 13:05
Industry Session VI
GE Healthcare International LLC
Building the future in theranostics

13:30 – 15:00
Novel Indication, Concepts & Genetics

15:30 – 17:00
Combination Therapies

17:00 – 17:30
Closing Ceremony

Invited Speakers

A

Abarca, Lorena (MINSAL, Chile)

Avila Rodriguez, Miguel (Autonomus University of Mexico, Mexico)

B

Babich, John (Ratio Therapeutics, USA)

Bachmann, Michael (FZ Dresden-Rossendorf, Germany)

Bal, Chandrasekhar (AIIMS, New Delhi, India)

Ballal, Sanjana (AIIMS, New Delhi, India)

Barbosa, Nataly (CTIC, Colombia)

Baum, Richard P. (Curanosticum, ICPO, Germany)

Bednarz, Bryan P. (Univ. Wisconsin, USA)

Beyer, Thomas (University Vienna, Austria)

Buchpiguel, Carlos (Hospital Sirio Libanes, Brasil)

C

Chen, Shawn (LNC, Singapore)

Cherry, Simon (UC Davis, USA)

Constanzo, Julie (INSERM, Montpellier, France)

Cutler, Cathy (Brookhaven National Laboratory, USA)

D

Delpassand, Ebrahim (RadioMedix / Excel Diagnostics, USA)

E

Eiber, Matthias (Technische Universität München, Germany)

Etchebehere, Elba (University of Campinas, Brasil)

Evans, Paul (GEHC, USA)

F

Flamen, Patrick (Hôpital Universitaire de Bruxelles, Belgium)

G

Gagnon, Katherine (GE Healthcare, Schweden)

Geshani, Munir (Mount Sinai, USA)

Gestin, Jean-Francois (COST, NOAR, France)

Giesel, Frederik (Heinrich Heine University Düsseldorf, Germany)

Goic, Carolina (PUCCH, Chile)

Gourni, Eleni (Inselspital Bern, Switzerland, Switzerland)

Greifenstein, Lukas (Curanosticum, Germany)

Günter, Thomas (UCSF Stanford, USA)

H-J

Herth, Matthias (University of Copenhagen, Denmark)

Hicks, Rodney (University of Melbourne and Monash University, Australia)

Hofman, Michael (PeterMac, Australia)

Huerta, Luis (Cchen, Chile)

Iagaru, Andrei (Stanford, USA)

Jeong, Jae Min (Seoul National University, South Korea)

K

Kjaer, Andreas (University of Copenhagen, Denmark)+

Korde, Aruna (IAEA, Austria)

Kossatz, Susanne (TU Munich, Germany)

Krause, Bernd (University Hospital Rostock, Germany)

Kulkarni, Harshad (BAMF, USA)

Kunikowska, Jolanta (Nuclear Medicine Department, Medical University of Warsaw, Poland)

L

Lapi, Suzanne (University of Alabama, USA)

Lewis, Jason (MSKCC, USA)

M

Maharaj, Masha (WARMTH, South Africa)

Mailman, Josh (Norcal, USA)

Martin, Marcel (TetraKit Technologies, Denmark)

Martin, Sergio (ALMA Observatory, Chile)

Matushita, Christina (SBMN, Brasil)

Mena Cortes, Danny (Hospital Angeles Lomas, Mexico)

Mock, Jacqueline (Philochem, Switzerland)

Mossesian, Sherly (Sofie Bioscience, USA)

N

Nadel, Helen (Stanford, USA)

P

Paganelli, Giovanni (European Institute of Oncology, Italy)

Perfecto Oliva, Juan (CENTIS, Cuba)

Pouget, Jean Pierre (INSERM, Montpellier, France)

Prasad, Vikas (Mallinkrodt Institute of Radiology, USA)

R

Radchenko, Valery (Triumf, University of British Columbia, Canada)

Racioppi, Silvia (Oncologic Institute Alex Fleming, Argentina)

Rey, Ana (Área Radioquímica, Facultad de Química, Universidad de la República, Uruguay)

Rösch, Frank (Johannes Gutenberg University Mainz, Germany)

S

Sarduy, Eduardo Aluicio (Wisconsin Cyclotron Lab, USA)

Sartor, Oliver (Mayo Clinic, USA)

Sathekge, Mike (University of Pretoria, South Africa)

Schultz, Michael (Perspective Therapeutics, USA)

Scott, Andrew (Olivia Newton John Cancer Research Institute, Australia)

Shi, Kuangyu (University of Bern, Switzerland)

Simecek, Jakub (Trimt, Germany)

Singh, Baljinder (PGIMER, Chandigarh, India)

van der Veken, Pieter (University of Antwerp, Belgium)

W

Watabe, Tadashi (Osaka University, Japan)

Weber, Wolfgang (TU Munich, Germany)

Werner, Rudolf (Frankfurt University Hospital, Germany)

Wirtz, Ralph (Stratifyer, Germany)

Z

Zan, Elcin (Weil Cornell University, USA)

Zhang, Jingjing (University of Singapore, Singapore)

Relive the Brilliance of TWC2024!

We extend our heartfelt gratitude to our esteemed sponsors, whose steadfast support was instrumental in making the Theranostics World Congress a resounding success. Dive into the invaluable contributions they made to advance medical science and reshape healthcare. Let's reminisce on the inspiring moments of TWC2024 and continue our journey towards transformative breakthroughs together!

Click here to explore the Sponsors Directory

Abstracts

In 2024 abstracts could be submitted for one of the following topics. The best abstracts were honored with the poster awards.

Prostate Cancer: Focuses on innovative approaches to diagnose, treat, and manage prostate cancer, including advancements in imaging techniques, targeted therapies, and personalized medicine approaches.
Neuroendocrine Tumors: Presents research on the diagnosis and treatment of neuroendocrine tumors, with a focus on theranostic applications for identifying and targeting these rare cancers.
Novel Targets & Chemistry: Showcases novel molecular targets and innovative chemical compounds for theranostic applications in cancer treatment, with an emphasis on improving specificity and efficacy.
Tumor Microenvironment:
- Diagnostics: Presents novel techniques for characterizing the tumor microenvironment, such as advanced imaging modalities and biomarker analysis, to guide treatment decisions.
- Therapeutics: Explores therapeutic strategies targeting the tumor microenvironment, including immunotherapies and stromal-targeted approaches, aimed at disrupting tumor growth and progression.
Combination Therapies: Highlights research on the synergistic effects of combining different treatment modalities, such as chemotherapy, radiotherapy, and immunotherapy, to enhance therapeutic outcomes and overcome treatment resistance.
Radioisotopes: Focuses on the use of radioisotopes in theranostic applications, including radiopharmaceuticals for imaging and targeted radionuclide therapy for cancer treatment.
Medical Physics & Instrumentation: Presents advancements in medical physics and instrumentation technologies, including imaging devices, radiation therapy delivery systems, and dosimetry methods, to improve precision and accuracy in cancer diagnosis and treatment.
Novel Indications, Genetics, Vaccinations: Explores emerging indications for theranostic approaches, such as rare cancers or specific genetic mutations, and investigates the potential of cancer vaccines in combination with theranostics for personalized treatment strategies.

Explore the Interactive ePoster Book!

Discover a comprehensive collection of ePosters showcased and discussed onsite at the event, now available for download in PDF format. Delve into the latest research and insights presented by leading experts in the field. Click below to download the ePoster book and explore the cutting-edge findings!

Download ePoster Book

TWC2024_ePoster-book.pdf

Awards

During the congress, awards were presented to recognize excellence in various fields. These awards honored the best abstracts, outstanding achievements in Theranostics, notable contributions to Nuclear Medicine, and remarkable accomplishments in radiopharmacy that are closely related to Theranostics.

The best three submitted Abstracts in recognition of outstanding work in Radiomolecular Precision Medicine were honored as part of the 7th Theranostic World Congress (TWC).

PSMA PET volume metrics estimated with artificial intelligence-based segmentation as predictor to 177Lu-iPSMA radioligand in patients with metastatic castrate resistant prostate cancer.

Irma Soldevilla Gallardo
Mexico City, Mexico

Preliminary comparison of 68Ga-FAPI-46 against 18F-FDG, 68Ga-DOTATATE and 68Ga-Pentixafor PET/CT/MR imaging in the assessment of various cancer types.

Habibollah Dadgar
Mashhad, Iran

Differences between α- and β-emitting targeted radiotherapy on the tumor microenvironment using single cell analysis in preclinical brain tumors.

Sydney Jackson
USA

Dr. Edwaldo Eduardo Camargo was a highly accomplished scientist and pioneer in the field of Nuclear Medicine. Born in Brazil in 1938, he obtained his medical degree and pursued his passion for Nuclear Medicine through advanced studies at Johns Hopkins University. He made significant contributions to the field in Brazil, implementing Nuclear Cardiology, developing radioisotope preparation and distribution, and promoting education and residency programs. Dr. Camargo held leadership positions, published numerous papers, and was admired for his humility and dedication to teaching.

The Edwaldo E. Camargo Young Investigator Award honors an individual who has made outstanding achievements in the field of Nuclear Medicine and which are related to Theranostics and was presented at the congress by Dr. Elcin Zan on March 22, 2024.

Award Winner

Dr. Sanjala Ballal
Department of Nuclear Medicine at All India Institute of Medical Sciences, India

Award Committee

Dr. Elcin Zan
Weil Cornell University, USA

Amount

3,000 US$

Number of Awards

one

Award Period

7^th Theranostic World Congress, Santiago, 2024

Sponsor

CMR Brazil, CEO: Sibila Grallert

The Saul Hertz Young Investigator Award honors outstanding achievement and excellence of early-career professionals in the field of theranostics and was presented at the congress by Prof. Dr. Susanne Kossatz on March 22, 2024.

Award Winner

Prof. Dr. Simone Krebs
Memorial Sloan Kettering Cancer Center, USA

Award Committee

Prof. Dr. Susanne Kossatz
TUM School of Medicine and Health, Germany

Amount

5,000 EUR

Number of Awards

one

Award Period

biannually

Sponsor

Academy of the International Centers for Precision Oncology. President: Professor Dr. Richard P. Baum

Dr. Jorge Nicolini was a Biochemist from Buenos Aires, Argentina and a pioneer in the field of radiopharmacy. As co-founder of the Argentinian Society of Nuclear Medicine, of Laboratorios Bacon, and as a brilliant scientist and teacher he made outstanding contributions to the field during his active carrer of over 50 years.

The Jorge Nicolini Young Investigator Award honors an individual who has made outstanding achievements in the field of radiopharmacy and which are related to Theranostics such as radiopharmaceutical development, isotope production, basic research, in-vitro and preclinical evaluation or translation of radiopharmaceuticals.

The award was presented at the congress by Prof. Dr. Susanne Kossatz on March 22, 2024.